Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PMGC Holdings Inc. (ELAB : NSDQ)

• Company Description    ELEVAI Labs Inc. is a medical aesthetic company developing cutting-edge physician-dispensed skin care applications. The company solves unmet needs in the medical aesthetics space through a combination of cutting-edge science-driven and next-generation consumer applications. ELEVAI Labs Inc. is based in NEWPORT BEACH, Calif. Number of Employees: 34

• Price / Volume Information    Yesterday's Closing Price: $5.21 Daily Weekly Monthly 20 Day Moving Average: 62,877 shares Shares Outstanding: 0.81 (millions) Market Capitalization: $4.22 (millions) Beta: -0.29 52 Week High: $2,548.80 52 Week Low: $4.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -43.37% -43.12% 12 Week -64.32% -65.07% Year To Date -98.53% -98.70%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 120 NEWPORT CENTER DRIVE STE 249 - NEWPORT BEACH,CA 92660 USA ph: 888-445-4886 fax: - ir@pmgcholdings.com https://pmgcholdings.com

• General Corporate Information    Officers Graydon Bensler - Chief Executive Officer and Chief Financial Office Braeden Lichti - Chairman Jeffrey Parry - Director Juliana Daley - Director George Kovalyov - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: DIVERSIFIED OPS Sector: Multi-Sector Conglomerates CUSIP: 73017P607 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 0.81 Most Recent Split Date: 8.00 (0.10:1) Beta: -0.29 Market Capitalization: $4.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.19 Price/Cash Flow: - Price / Sales: 1.64 EPS Growth vs. Year Ago Period: 98.42% vs. Previous Quarter: 94.56% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 91.64% ROE 06/30/26 - -118.83 03/31/26 - -117.82 12/31/25 - -92.90 ROA 06/30/26 - -60.03 03/31/26 - -70.79 12/31/25 - -67.56 Current Ratio 06/30/26 - 1.36 03/31/26 - 1.45 12/31/25 - 1.74 Quick Ratio 06/30/26 - 1.30 03/31/26 - 1.43 12/31/25 - 1.72 Operating Margin 06/30/26 - -526.06 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - -522.92 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - -524.82 03/31/26 - -877.04 12/31/25 - -1,313.56 Book Value 06/30/26 - 27.20 03/31/26 - 108.75 12/31/25 - 933.34 Inventory Turnover 06/30/26 - 5.04 03/31/26 - 7.18 12/31/25 - 7.25 Debt-to-Equity 06/30/26 - 0.02 03/31/26 - 0.03 12/31/25 - 0.01 Debt-to-Capital 06/30/26 - 1.61 03/31/26 - 2.77 12/31/25 - 1.07

Powered by Zacks Investment Research ©